Site Under Development, Content Population and SEO, Soft Launch 1st January 2020
The progestin intrauterine contraceptive device is called the intrauterine system (IUS). It releases low doses of progestin over a period of three to seven years, to prevent pregnancy by multiple mechanisms.
Use of the IUS has several advantages such as:
The use of the IUS is associated with some drawbacks:
Breast cancer risk is slightly increased in women who have used the IUS, including both ductal and lobular types of breast carcinoma. If pregnancy occurs, ectopic gestation is more likely due to the effect on the tubes and the endometrium
The use of the IUS is contraindicated in women suffering from any of the following: